Annual Zoledronic Acid for the Treatment of Osteoporosis: A Randomized Controlled Trial
Context: Osteoporosis remains a significant public health problem in many parts of the world, including India. The efficacy of oral bisphosphonates is lower because of poor compliance. Annual treatment with zoledronic acid has been reported to improve outcomes. Objective: To study the benefits and s...
Saved in:
Main Authors: | Asif Hussain, Sushil Kumar Saini, Jaydeep Patel, Chandra Prakash Pal, Hemant Singh Chahar, Rohit Yadav |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2023-01-01
|
Series: | Journal of Orthopedics, Traumatology and Rehabilitation |
Subjects: | |
Online Access: | https://journals.lww.com/10.4103/jotr.jotr_58_22 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Risk Factors for Acute Febrile Reaction after Zoledronic Acid Treatment for Primary Osteoporosis
by: WU Hongliang, et al.
Published: (2022-06-01) -
PREVENTION OF COMPLICATIONS IN CASTRATE-REFRACTORY PROSTATE CANCER PATIENTS WITH BONE METASTASES
by: K. M. Nushko, et al.
Published: (2015-10-01) -
The effect of denosumab vs. zoledronic acid in preventing skeletal-related events, including pain-related bone metastasis: a systematic review
by: I. Putu Eka Widyadharma, et al.
Published: (2024-10-01) -
Comprehensive evaluation of compound Kushen injection combined with zoledronic acid in treating bone metastasis cancer pain based on meta-analysis and decision tree model
by: Xi Zhao, et al.
Published: (2025-01-01) -
Osteoporosis: A silent epidemic
by: Yusimí Isaguirre Martínez, et al.
Published: (2006-04-01)